Literature for RXPA380 (M02.004 inhibitor)

(Topics flags: S Structure, I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

2012
1. Anthony,C.S., Masuyer,G., Sturrock,E.D. and Acharya,K.R.
   Structure based drug design of angiotensin-I converting enzyme inhibitors
   Curr Med Chem (2012) 19, 845-855. PubMed  Europe PubMed DOI  I
2011
2. Akif,M., Schwager,S.L., Anthony,C.S., Czarny,B., Beau,F., Dive,V., Sturrock,E.D. and Acharya,K.R.
   Novel mechanism of inhibition of human angiotensin-I-converting enzyme (ACE) by a highly specific phosphinic tripeptide
   Biochem J (2011) 436, 53-59. PubMed  Europe PubMed DOI  S  I
2009
3. Kroger,W.L., Douglas,R.G., O'Neill,H.G., Dive,V. and Sturrock,E.D.
   Investigating the domain specificity of phosphinic inhibitors RXPA380 and RXP407 in angiotensin-converting enzyme
   Biochemistry (2009) 48, 8405-8412. PubMed  Europe PubMed DOI  I
2007
4. Corradi,H.R., Chitapi,I., Sewell,B.T., Georgiadis,D., Dive,V., Sturrock,E.D. and Acharya,K.R.
   The structure of testis angiotensin-converting enzyme in complex with the C domain-specific inhibitor RXPA380
   Biochemistry (2007) 46, 5473-5478. PubMed  Europe PubMed DOI  S  I
2004
5. Georgiadis,D., Cuniasse,P., Cotton,J., Yiotakis,A. and Dive,V.
   Structural determinants of RXPA380, a potent and highly selective inhibitor of the angiotensin-converting enzyme C-domain
   Biochemistry (2004) 43, 8048-8054. PubMed  Europe PubMed DOI  I
2003
6. Georgiadis,D., Beau,F., Czarny,B., Cotton,J., Yiotakis,A. and Dive,V.
   Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors
   Circ Res (2003) 93, 148-154. PubMed  Europe PubMed DOI  I